https://pubmed.ncbi.nlm.nih.gov/35626323/ cholestasis

Diagnostics (Basel). 2022 May 7;12(5):1169.
doi: 10.3390/diagnostics12051169.

Targeted-Capture Next-Generation Sequencing in Diagnosis Approach of Pediatric Cholestasis

Marion Almes 1 2 3, Anne Spraul 2 3 4, Mathias Ruiz 5, Muriel Girard 6, Bertrand Roquelaure 7, Nolwenn Laborde 8, Fréderic Gottrand 9, Anne Turquet 10, Thierry Lamireau 11, Alain Dabadie 12, Marjorie Bonneton 13, Alice Thebaut 1 2, Babara Rohmer 5, Florence Lacaille 6, Pierre Broué 8, Alexandre Fabre 7, Karine Mention-Mulliez 9, Jérôme Bouligand 3 14 15, Emmanuel Jacquemin 1 2 3, Emmanuel Gonzales 1 2 3

Abstract

Background: Cholestasis is a frequent and severe condition during childhood. Genetic cholestatic diseases represent up to 25% of pediatric cholestasis. Molecular analysis by targeted-capture next generation sequencing (NGS) has recently emerged as an efficient diagnostic tool. The objective of this study is to evaluate the use of NGS in children with cholestasis.

Methods: Children presenting cholestasis were included between 2015 and 2020. Molecular sequencing was performed by targeted capture of a panel of 34 genes involved in cholestasis and jaundice. Patients were classified into three categories: certain diagnosis; suggested diagnosis (when genotype was consistent with phenotype for conditions without any available OMIM or ORPHANET-number); uncertain diagnosis (when clinical and para-clinical findings were not consistent enough with molecular findings).

Results: A certain diagnosis was established in 169 patients among the 602 included (28.1%). Molecular studies led to a suggested diagnosis in 40 patients (6.6%) and to an uncertain diagnosis in 21 patients (3.5%). In 372 children (61.7%), no molecular defect was identified.

Conclusions: NGS is a useful diagnostic tool in pediatric cholestasis, providing a certain diagnosis in 28.1% of the patients included in this study. In the remaining patients, especially those with variants of uncertain significance, the imputability of the variants requires further investigations.